UM1TR004400
Cooperative Agreement
Overview
Grant Description
Einstein-Montefiore Clinical and Translational Science Award Hub - The Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at the Albert Einstein College of Medicine and Montefiore Medical Center serves as the home of our CTSA program.
The vision of the ICTR is to improve the health of the Bronx, and other communities that disproportionately and unjustly suffer from poor health and premature death, by accelerating the translation of biomedical discoveries into effective and sustainable disease prevention and treatment strategies.
Created in 2007, the ICTR has transformed clinical and translational research (CTR) throughout Einstein and Montefiore by creating a robust research environment; re-engineering CTR processes; integrating research and healthcare; and developing strong community relationships.
The ICTR theme of "Building Bridges in the Bronx and Beyond" underscores the importance of bridging gaps between our researchers, health system leaders, clinicians, patients, communities, and CTSA partners to advance translational science and health equity.
The specific aims of the ICTR are to:
(1) Catalyze innovations that will enhance the efficiency and effectiveness of translational research. We will support and fund studies with high potential to overcome major CTR roadblocks and health inequities; create methodological and informatics translational science innovations; improve CTR operations, and enhance dissemination and implementation strategies.
(2) Engage communities, patients, and other partners early and throughout the translational process. Our new community and stakeholder engagement research module will transform our learning health system into a "learning health research community"; promote active and continuous bidirectional communication with communities, patients, and other partners; facilitate research to identify and mitigate social determinants of health, and enhance uptake of evidence-based programs by target populations.
(3) Develop and implement state-of-the-art clinical research and informatics resources and services to improve the rigor, safety, efficiency, effectiveness, and generalizability of CTR.
(4) Train, develop, and maintain a skilled, multidisciplinary, and diverse translational workforce to support and lead high-quality research with new training and pathway programs to ensure members of historically excluded groups engage in CTR and become research leaders.
(5) Partner with other CTSA hubs and the CTSA Consortium to accelerate CTR and rapidly respond to urgent public health needs.
Our aims are aligned with the new CTSA program goals and will enable the ICTR to maximally contribute to the collective efforts of the national collaborative CTSA Consortium to deliver more treatments to more patients more quickly in the Bronx and beyond.
The vision of the ICTR is to improve the health of the Bronx, and other communities that disproportionately and unjustly suffer from poor health and premature death, by accelerating the translation of biomedical discoveries into effective and sustainable disease prevention and treatment strategies.
Created in 2007, the ICTR has transformed clinical and translational research (CTR) throughout Einstein and Montefiore by creating a robust research environment; re-engineering CTR processes; integrating research and healthcare; and developing strong community relationships.
The ICTR theme of "Building Bridges in the Bronx and Beyond" underscores the importance of bridging gaps between our researchers, health system leaders, clinicians, patients, communities, and CTSA partners to advance translational science and health equity.
The specific aims of the ICTR are to:
(1) Catalyze innovations that will enhance the efficiency and effectiveness of translational research. We will support and fund studies with high potential to overcome major CTR roadblocks and health inequities; create methodological and informatics translational science innovations; improve CTR operations, and enhance dissemination and implementation strategies.
(2) Engage communities, patients, and other partners early and throughout the translational process. Our new community and stakeholder engagement research module will transform our learning health system into a "learning health research community"; promote active and continuous bidirectional communication with communities, patients, and other partners; facilitate research to identify and mitigate social determinants of health, and enhance uptake of evidence-based programs by target populations.
(3) Develop and implement state-of-the-art clinical research and informatics resources and services to improve the rigor, safety, efficiency, effectiveness, and generalizability of CTR.
(4) Train, develop, and maintain a skilled, multidisciplinary, and diverse translational workforce to support and lead high-quality research with new training and pathway programs to ensure members of historically excluded groups engage in CTR and become research leaders.
(5) Partner with other CTSA hubs and the CTSA Consortium to accelerate CTR and rapidly respond to urgent public health needs.
Our aims are aligned with the new CTSA program goals and will enable the ICTR to maximally contribute to the collective efforts of the national collaborative CTSA Consortium to deliver more treatments to more patients more quickly in the Bronx and beyond.
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Bronx,
New York
10461
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 49% from $8,736,000 to $13,001,820.
Albert Einstein College Of Medicine was awarded
Einstein-Montefiore Clinical and Translational Science Award Hub
Cooperative Agreement UM1TR004400
worth $13,001,820
from National Center for Advancing Translational Sciences in March 2023 with work to be completed primarily in Bronx New York United States.
The grant
has a duration of 7 years and
was awarded through assistance program 93.350 National Center for Advancing Translational Sciences.
The Cooperative Agreement was awarded through grant opportunity Clinical and Translational Science Award (UM1 Clinical Trial Optional).
Status
(Ongoing)
Last Modified 7/21/25
Period of Performance
3/3/23
Start Date
2/28/30
End Date
Funding Split
$13.0M
Federal Obligation
$0.0
Non-Federal Obligation
$13.0M
Total Obligated
Activity Timeline
Transaction History
Modifications to UM1TR004400
Additional Detail
Award ID FAIN
UM1TR004400
SAI Number
UM1TR004400-2160964224
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NR00 NIH National Center for Advancing Translational Sciences
Funding Office
75NR00 NIH National Center for Advancing Translational Sciences
Awardee UEI
H6N1ZF5HJ2G3
Awardee CAGE
87UV8
Performance District
NY-14
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Center for Advancing Translational Sciences, National Institutes of Health, Health and Human Services (075-0875) | Health research and training | Grants, subsidies, and contributions (41.0) | $4,368,000 | 100% |
Modified: 7/21/25